OPENING HORIZONS TO ACCESS CURES
Welcome to ADN Genomix. We are a team of passionate and determined scientists, business people, and mensch in Cambridge, MA, on a mission to deliver lifesaving pharmaceutical and biologic drugs where cures previously have not been available.
We are building our portfolio. Check back for updates.
$160B is spent worldwide annually on drug R&D, at an average cost of $2.6B per new molecule. Yet 15 out of 24 fail to cross the valley of death between animal and people, 8 of the remaining 9 promising cures fail in clinical trials, and those that pass are increasingly less helpful than planned (for example, almost 70% of Alzheimer's medications are ineffective) or may even harm phenotypic sub-populations (almost 8%). We can do better.
At ADN Genomix, we partner with pathbreaking biopharmaceutical companies and research institutions to identify and translate new therapeutics that can treat unmet needs in rare diseases, oncology, neurology, and cardiology. We believe the search for cures has no borders and that the right understanding and technological edge can unlock undertappedpotential.